rs121434440
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The ENST00000366647.9(GNPAT):c.631C>T(p.Arg211Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000549 in 1,457,372 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R211H) has been classified as Pathogenic.
Frequency
Consequence
ENST00000366647.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GNPAT | NM_014236.4 | c.631C>T | p.Arg211Cys | missense_variant | 5/16 | ENST00000366647.9 | NP_055051.1 | |
GNPAT | NM_001316350.2 | c.448C>T | p.Arg150Cys | missense_variant | 4/15 | NP_001303279.1 | ||
GNPAT | XM_005273313.5 | c.628C>T | p.Arg210Cys | missense_variant | 5/16 | XP_005273370.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GNPAT | ENST00000366647.9 | c.631C>T | p.Arg211Cys | missense_variant | 5/16 | 1 | NM_014236.4 | ENSP00000355607 | P1 | |
GNPAT | ENST00000416000.1 | c.601C>T | p.Arg201Cys | missense_variant | 5/13 | 5 | ENSP00000411640 | |||
GNPAT | ENST00000436239.5 | c.448C>T | p.Arg150Cys | missense_variant | 4/6 | 3 | ENSP00000402811 | |||
GNPAT | ENST00000644483.1 | c.*317C>T | 3_prime_UTR_variant, NMD_transcript_variant | 6/17 | ENSP00000496537 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000795 AC: 2AN: 251464Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135906
GnomAD4 exome AF: 0.00000549 AC: 8AN: 1457372Hom.: 0 Cov.: 29 AF XY: 0.00000689 AC XY: 5AN XY: 725404
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Rhizomelic chondrodysplasia punctata type 2 Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | May 01, 1998 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Aug 15, 2023 | - - |
Rhizomelic chondrodysplasia punctata Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | May 22, 2023 | Variant summary: GNPAT c.631C>T (p.Arg211Cys) results in a non-conservative amino acid change located in the Phospholipid/glycerol acyltransferase (IPR002123) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 251464 control chromosomes. c.631C>T has been reported in the literature in individuals affected with Rhizomelic Chondrodysplasia Punctata (Ofman_2001). At least one publication reports experimental evidence evaluating an impact on protein function indicating no GNPAT enzyme activity in a homozygous individual (Ofman_2001). Another variant affecting the same amino acid (p.Arg211His, pathogenic in ClinVar) has been observed in homozygous individuals with no GNPAT activity suggesting an important role of this variant in disease. The following publication have been ascertained in the context of this evaluation (PMID: 11237722).No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at